top of page

Case Study –
Enclara Pharmacia

Enclara is the nation’s largest full-service pharmacy benefits manager (PBM) specifically for the hospice and palliative care sectors. Serving over 450 customers and nearly 100,000 patients nationally, Enclara works closely with hospices to reduce pharmacy costs, improve patient care and support caregivers.

Enclara screen 2.PNG

Andy Horowitz, CEO

"We greatly enjoyed working with the Consonance team. They have been a critical partner throughout Enclara’s evolution over the past five years from a  small hospice-focused pharmacy into a national full-service specialized pharmacy management platform."*

Initial Investment

March 2014

Partnered with founder and CEO, Andrew Horowitz to recapitalize Enclara and fund organic and inorganic growth

Transformational Public Company Carve-Out

August 2014

Acquired ExcelleRx, Inc. and PBM Holdings, two division of Omnicare (NYSE: OCR), and combined with Enclara to build the clear market leader

Strategic Partners

2014 - 2020

Made significant investments in infrastructure, processes, and new market development to support larger enterprise and drive growth

Creation of Turn-Key Health

2015 - 2020

Incubated a start-up business within Enclara, Turn-Key Health, that serves health plans, provider organizations and their members who are experiencing a serious or advanced illness through its Palliative Illness Management model to improve care quality, address costs and reduce burdens associated with life-limiting illnesses. 

Turn-Key Health acquired by CareCentrix in May 2020

Tuck-In Acquisition

May 2019

In partnership with Management, Consonance sourced and closed the acquisition of Avanti Health Care Services

Acquired by Humana (NYSE: HUM)

January 2020

Humana acquires Enclara from Consonance Capital Partners

*As a result of being a former CEO of a CCP portfolio company, Andy Horowitz may have been inclined to have a favorable view of CCP.

bottom of page